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ABSTRACT
Objectives This study assesses whether the observed
declines in HIV prevalence since the beginning of the
‘Avahan’ India HIV/AIDS prevention initiative are
consistent with self-reported increases in condom use by
female sex workers (FSWs) in two districts of southern
India, and provides estimates of the fraction of new
infections averted among FSWs and clients due to
increases in condom use in commercial sex after 2004.
Methods A deterministic compartmental model of
HIV/sexually transmitted infection (STI) transmission
incorporating heterogeneous sexual behaviour was
developed, parameterised and fitted using data from two
districts in Karnataka, India. Three hypotheses of condom
use among FSWs were tested: (H0), that condom use
increased in line with reported FSW survey data prior to
the Avahan initiative but remained constant afterwards;
(H1) that condom use increased following the Avahan
initiative, in accordance with survey data; (H2) that
condom use increased according to estimates derived
from condom distribution data. The proportion of fits to
HIV/STI prevalence data was examined to determine
which hypothesis was most consistent.
Results For Mysore 0/36/82.7 fits were identified per
million parameter sets explored under hypothesis H0/H1/
H2, respectively, while for Belgaum 9.7/8.3/0 fits were
identified. The HIV epidemics in Belgaum and Mysore are
both declining. In Mysore, increases in condom use
during commercial sex between 2004 and 2009 may
have averted 31.2% to 47.4% of new HIV infections in
FSWs, while in Belgaum it may have averted 24.8% to
43.2%, if there was an increase in condom use.
Discussion Increased condom use following the Avahan
intervention is likely to have played a role in curbing the
HIV epidemic in Mysore. In Belgaum, given the limitations
in available data, this method cannot be used alone to
decide if there has been an increase in condom use.
INTRODUCTION
Karnataka, in southern India, has one of the highest
prevalences of HIV among Indian states,1 and is
among the states included in the ‘Avahan’ India HIV/
AIDS initiative established by the Bill & Melinda
Gates Foundation in 2004. Working through state-
level partners and local non-governmental organisa-
tions (NGOs), the initiative is a multifaceted HIV
preventive intervention promoting prevention
strategies among high-risk groups, including distri-
bution of condoms to and promotion of condom use
among female sex workers (FSWs).2e4
Assessing the impact of the Avahan intervention
is crucial, not only to ensure that Avahan achieves
its goals of reducing HIV transmission in India, but
also to inform future large-scale interventions.5
However, the dynamics of an HIV epidemic are
complicated: declines in HIV prevalence can occur
without any intervention effects, due to natural
infection dynamics and, conversely, increases can
occur even in the presence of an effective interven-
tion.6 7 In order to separate out the impact of the
Avahan initiative from natural HIV transmission
dynamics, and because of the difﬁculty and huge
expense of implementing community randomised
controlled trials, a tailor-made transmission
dynamics model will be used as one important
component of the impact assessment, the frame-
work for which is described in Boily et al.8
The ﬁnal impact and cost effectiveness analysis,
planned for 2011, will estimate the impact of the
Avahan initiative on the HIV and sexually trans-
mitted infection (STI) epidemics among high-risk
groups and the broader population across more
than 30 intervention sites.5 8 This paper presents
the results of an interim analysis focusing on FSWs
and their clients in two districts where sufﬁcient
data are currently available, and which represent
different HIV/STI epidemic trends and behavioural
proﬁles: Belgaum Urban, a higher prevalence district
in which Avahan was not the ﬁrst but is now the
only intervention; and Mysore Urban, a lower
prevalence district in which Avahan was the ﬁrst
and remains the only intervention.
The objective of this analysis is to determine
whether the observed changes in HIV prevalence
among FSWs could be solely due to natural disease
dynamics rather than to a change in condom use
following the intervention. We address this ques-
tion by testing whether the null hypothesis (H0) of
stable (ie, no increase in) condom use following the
initiation of the Avahan intervention in 2004 is less
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likely than the alternative hypotheses (H1) that condom use
actually increased by as much as reported in FSW survey data, or
(H2) that there was a lower level of preintervention condom use
and a sharper postintervention increase than indicated by FSW
survey data, as suggested by records of condom availability.9
METHODS
In order to model the HIV/STI epidemics in urban Belgaum and
Mysore districts, an in-depth mathematical modelling analysis
was undertaken with the key elements described below.
Methodological framework of evaluation
The structure of the evaluation follows the methodological
framework designed and described in Boily et al.8 In short,
a mathematical model was used within a Bayesian framework,
where available data were ﬁrst used to specify what was known
about each model parameter by deﬁning a plausible range of
values (the ‘prior distribution’). This distribution was then
randomly sampled repeatedly, to test the model with a large
number of parameter combinations and identify those parameter
sets (the ‘posterior distribution’) that agreed with the empirical
HIV/STI prevalence data shown in table 1.
One of the advantages of this approach is that the percentage
of parameter sets producing a model ﬁt to the prevalence data
gives a measure of how compatible the prior parameter sets were
with the observed prevalence data for the speciﬁed model. This
approach was used here to test the three hypotheses described
above concerning possible trends in condom use before and after
the Avahan intervention. Finally, the posterior distribution was
used to simulate a control group without the intervention,
which was then compared to the original scenario to produce
estimates of intervention impact.
Model structure and parameterisation
A purpose-built deterministic compartmental model of HIV,
herpes simplex virus (HSV)-2 and syphilis transmission was
constructed and parameterised to incorporate key aspects and
heterogeneities of the complex FSW and client structure speciﬁc
to each setting.10 In summary, the model consisted of an open
population,growingat the ratedescribedbycensusdata,11 stratiﬁed
into ‘high-risk’ (FSWs and their clients) and ‘low-risk’ (the
remaining population) groups. Based on work by Vickerman et al4
(see page 33), it was assumed in this model that there is
no transmission between low-risk individuals. The high-risk
groups (FSWs and their clients) were further stratiﬁed by variables
showing strong associations with HIV prevalence and high-risk
behaviour in analyses of data from serial cross-sectional surveys
termed integrated behavioural and biological assessments
(IBBAs).10 12
The model simulates the transmission of HIV/STIs between
FSWs and their clients through commercial and longer-term
non-commercial partnerships, and the bridging infections from
clients to low-risk women through their non-commercial part-
nerships, as shown in ﬁgure 1. The force of infection depends on
the disease-speciﬁc infectivity, type and duration of partnership,
frequency of sex acts for the type of partnership, condom use and
STI coinfection status of both partners. The three parameters
inﬂuencing HIV prevalence the most in a sensitivity analysis of
a representative sample of the unrestricted model runs were the
number of sex acts per partnership between FSWs and occasional
clients, the male to female HIV transmission per sex act and the
RR for increased transmissibility of primary HIV. Further details
of the model and equations are provided in the supplementary
material.
HIV was modelled with an initial short acute phase of high
infectivity, followed by a long low-infectivity phase and a pre-
AIDS phase of increased infectivity.13 It was assumed that those
with AIDS are chronically ill, and cease being sexually active.
HSV-2 coinfection14 and syphilis15 were also modelled dynami-
cally, with cofactors representing facilitation of HIV and HSV-2
acquisition and transmission.
The setting-speciﬁc behaviour-related, demographic-related
and intervention-related prior model parameter distributions
were derived from detailed serial cross-sectional behavioural and
biological data (from IBBAs) collected from FSWs and their
clients, and general population surveys (GPS) carried out as part
of the Avahan monitoring programme, as well as from
complementary data from other sources. The non-setting
speciﬁc biological parameter ranges were based on reviews of
relevant literature (tables 2 and 3). Prior distributions were
assumed to be uniform across each parameter range; this was
a ‘conservative’ choice to reﬂect the lack of precise knowledge
Table 1 HIV/sexually transmitted infection (STI) prevalence data from
integrated behavioural and biological assessment (IBBA) surveys in
Belgaum and Mysore used to fit (FSW IBBA rounds 1 and 2, and client
IBBA round 1) and validate (FSW IBBA rounds 2 and 3) the model
Survey
District and date
carried out
CI for prevalence
HIV HSV-2 Syphilis
Fitting data
FSW IBBA
round 1
Mysore
(August 2004)
21.9% to 30.3% 59.6% to 69.1% 21.0% to 29.0%
Belgaum
(October 2005)
27.6% to 40.2% 78.6% to 89.1% 3.0% to 13.0%
Client IBBA
Round 1 Mysore
(October 2008)
3.2% to 7.6% 8.0% to 33.0% 1.3% to 4.6%
Belgaum
(October 2007)
3.6% to 8.8% 23.3% to 32.3% 2.0% to 6.5%
Crossvalidation and fitting data
FSW IBBA
round 2
Mysore
(December 2006)
19.1% to 29.5%
Belgaum
(July 2008)
22.2% to 32.5%
Crossvalidation data
FSW IBBA
round 3
Mysore
(April 2009)
8.11% to 14.1%
FSW, female sex worker; HSV, herpes simplex virus.
Men starting 
and ceasing 
buying sex
Female sex 
workers Male clients
Female
lower risk
Male lower 
risk
Bridging infections 
due to sex with 
casual and main 
partners
Women
starting and 
ceasing sex 
work
Commercial
Main
Figure 1 Outline of the main aspects of sexual behaviour structure and
population movements between risk groups that are included in the
model. HIV/sexually transmitted infection (STI) transmission through
main (plain arrow) and casual (dotted arrow) partnerships is shown.
Female sex workers and clients engage in commercial sex for a time
before returning to the general population and being replaced from the
general population (thick arrow).
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and possibility of bias in the data used to estimate the
parameters.
The parameterisation of condom use before and after the
intervention was data driven and speciﬁc to each hypothesis
tested, resulting in three different prior condom use distribu-
tions. The prior distribution of condom use for hypothesis H1
was based on estimates (with CIs) of site-speciﬁc condom use
from 2001 onwards given by the analysis of Lowndes et al.75 That
analysis used data from the IBBA round 2 surveys concerning
time since starting to use condoms consistently with occasional
clients to retrospectively ‘reconstruct’ the fraction of FSWs
consistently using condoms each year from 2001 to the year of
the survey. The null hypothesis H0 assumed the same increase in
condom use prior to 2004 as hypothesis H1 but no further
increase after the start of the Avahan intervention in 2004. A
further hypothesis (H2) was based on HIV prevention
programme data and other sources regarding the availability of
condoms for FSWs9 from 2004 to 2008 across Karnataka. This
study suggested that the proportion of consistent condom users
among FSWs in 2004 was much lower than suggested in
hypothesis H1 due to low availability, but that it rose steeply
during 2006e2008 due to the Avahan intervention. The three
different condom prior distributions are shown in ﬁgure 2, with
the round 1 and 2 FSW IBBA point estimates shown for
comparison.
Parametric uncertainty analysis, model fitting and validation
This step involved identifying combinations of model parame-
ters that agreed with (‘ﬁt’) the HIV/STI prevalence data from
each site for each condom use hypothesis tested. Latin hypercube
sampling (LHS) was used to sample several million parameter
sets from all ‘prior ’ parameter ranges for each hypothesis and
district, with the sampling done so that the same set of param-
eters, excluding the intervention parameters being tested, were
used for the different hypotheses in each district. The model was
run with each sampled parameter set to predict HIV/STI prev-
alences. A parameter set was accepted as a ﬁt if the model
predictions simultaneously lay within the 95% CIs of the HIV,
HSV-2 and syphilis prevalence data of the relevant FSW and
client IBBAs, as described below.
The HIV/STI prevalence data from FSWs and clients for each
district were used in two stages: (1) as validation and (2) for
hypothesis testing. In stage 1, the model was ﬁrst ﬁtted to just
the round 1 FSW and client IBBA HIV, HSV-2 and syphilis
prevalence data (see table 1), and the predictive value of these
model ﬁts was assessed against the HIV prevalence data not used
directly at this stage of the ﬁtting process, namely FSW HIV
prevalence from the second round FSW IBBA in Mysore and
Belgaum (table 1) and third round in Mysore (table 1), and FSW
HIV prevalence by typology (street, brothel or home based) in
rounds 1 and 2 (see supplementary material). In stage 2, the
second round of IBBA HIV prevalence data were included in the
ﬁtting procedure along with the ﬁrst round of FSW and client
IBBA HIV/STI prevalence data (table 1) to produce a reduced set
of model ﬁts for hypothesis testing.
Testing hypotheses of condom use
The most likely condom use hypothesis was determined based
on the relative proportions of ﬁts to the ﬁrst round FSW and
client IBBA HIV/STI prevalence data and the second round FSW
HIV prevalence data. For each hypothesis, the fraction of model
ﬁts from all parameter sets was compared to determine which
hypothesis was more likely. This method, which is related to the
version of Approximate Bayesian Computing as described by
Weiss and von Haeseler,76 is also similar to the Bayesian methods
used by Vickerman et al for determining the likelihood of
different injecting drug user risk behaviour scenarios in
Pakistan,77 and Hallett et al for examining behaviour change in
Zimbabwe.78
Impact analysis
The posterior distribution of the most likely condom use
hypothesis was used to simulate HIV prevalence and incidence
over time following the start of the intervention, and in
a matched control population. In the latter, each model ﬁt was
run again with condom use kept constant at 2004 levels (ie, at
the start of the Avahan initiative). Comparing the impact and
control scenarios, estimates of the impact of the increase in
condom use following the start of the intervention among high-
risk groups were derived for a 5-year period (2004e2009). These
estimates derived from the posterior distribution include credi-
bility intervals (CrI) generated by using all the parameter
combinations that ﬁt the prevalence data to reﬂect the uncer-
tainty in parameter assumptions, since more than one set of
parameters may produce an equally good ﬁt to epidemiological
trends.
RESULTS
Hypothesis testing
The proportion of ﬁts to each hypothesis is shown in table 4. In
Mysore, the hypothesis H2, derived from analysing availability of
condoms, gives the largest proportion of simulations which are
consistent with prevalence data, and scenarios H2 and H1 of
increasing condom use following the introduction of Avahan are
more likely than the null hypothesis H0 of no condom increase
after the start of Avahan, for which no model ﬁts were obtained.
In Belgaum, however, the null hypothesis H0 of no increase use in
condom use following Avahan and the alternative hypothesis H1,
based on the historical condom use reconstruction, cannot be
distinguished by this method, although both are much more
likely than the hypothesis H2. An alternative method to
comparing the proportion of ﬁts would be a likelihood-based
approach, calculating the likelihood for each run; however this
method gave comparable results (data not shown).
Crossvalidation of results
Table 4 shows that ﬁts to only the round 1 FSWand client IBBA
prevalence data (table 4) also generally ﬁt the round 2 FSW IBBA
HIV prevalence data well for all hypotheses (90% or more of
posterior runs also ﬁt FSW HIV round 2 prevalence). This then
validates the model with respect to time trends in HIV (see also
supplementary material). A third round of IBBA data was avail-
able for Mysore only, and the model HIV prevalence projections
were slightly higher (12.1% to 20.6% for H2; 12.4% to 19.6% for
H1) than the third round IBBA data (8.1% to 14.1%). This is
consistent with the fact that any further increases subsequent to
the IBBA round 2 in condom use were not incorporated in the
model.
Lastly, validation of the model by comparing its projections
with FSW HIV prevalence by typology generally showed good
agreement, although there was some residual heterogeneity, as
might be expected (see supplementary material).
Trends in HIV/STI prevalence and incidence
The predicted prevalences over time for the model ﬁts from the
favoured hypotheses (H0 and H1 for Belgaum and H2 for Mysore)
suggest that the HIV epidemics among FSWs and clients are
declining in both districts (ﬁgure 3AeF). In Belgaum, it is likely
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Table 2 Prior biological model input parameters sampled at the fitting stage to obtain the posterior parameter sets for Mysore and Belgaum for the
Avahan impact model (all durations are in months)
Types of model input Definition of model input Model inputs Reference for model input value
Duration of
infection stages
Average duration of Ng/Ct: Reviewed in Korenromp et al.16 Also depends on level of STI
treatment.Males 2e5
Females 2e12
Female sex workers (FSWs) 0.5e3
Average duration of syphilis stages: Available data was reviewed by Boily et al and
Garnett et al8 15Primary (no treatment) 1.51
Secondary (no treatment) 3e4.5
Primary and secondary stage (with treatment) 1e5
Latent phase (including treatment) 2e24
Time between potential recurrences 6
Immune/resistant phase 12e60
Average duration of HSV-2 stages: From Cheong et al, Corey et al, Diamond et al, Koelle et al,
Guinan et al and Benedetti et al.17e24
Using Corey et al, Guinan et al and Wald et al.18 20 23 25e27
Primary stage 0.36e0.66
Symptomatic recurrence 0.1e0.16
Rate of HSV-2 symptomatic recurrences while:
HIV negative 0.09e0.41 Corey et al, Diamond et al, Benedetti et al, Lafferty et al and
Kim et al18 20 21 24 28e30
HIV positive 1e23HIV negative rate Using Schacker et al and Conant et al31 32
Average duration of HIV stages: Based on Grover and Shivraj, and Kumarasamy et al33 34
Initial HIV high viraemia phase 4e6
Between initial high viraemia and pre-AIDS 70e90.5
Pre-AIDS high viraemia phase 6e18
Transmission
probabilities
Probability of HIV transmission per sex act: Reviewed in Holmes et al.40 67
Male to female: 0.0006e0.0011
Female to male 0.0001e0.0014
Sexual transmission multiplicative cofactor:
Initial high viraemia phase 4.5e18.8
Pre-AIDS high viraemia phase 4.5e11.9
Probability of Ng/Ct transmission per sex act 0.05e0.2 Reviewed by Holmes et al, Hooper et al40 67
Probability of syphilis transmission per sex act (male to
female):
0.1e0.3 Reviewed by Garnett et al15
Ratio of transmission probabilities female to male:male to
female
0.33e1.0
Probability of HSV-2 transmission:
Latent/asymptomatic shedding stage (male to female) 0.0005e0.002 Using Wald et al and Corey et al37 38
RR male to female: female to male transmission 2e5
Primary stage 2e636.7e25 times
asymptomatic/latent transmission
probability
From Kim et al, Wald et al and Corey et al30 37 38
Symptomatic recurrence stage 1e336.7e25
times latent/asymptomatic
transmission probability
Wald et al, Kim et al, and Mertz et al25 30 39e41
Cofactors for HIV Average Ng/Ct cofactor per sex act for increasing
susceptibility to HIV
1.2e2.5 Using Rottingen et al13
Average syphilis cofactor per sex act for increasing
susceptibility to HIV
2.1e3.3
HSV-2 cofactor per sex act for increasing HIV infectivity:
Primary and symptomatic recurrence phases 1.27e2.5731e2
Asymptomatic/latent phase 0.27e1.5730.04e0.1532e3
HSV-2 cofactor per sex act for increasing HIV susceptibility: Using Schacker et al, Nagot et al, Zuckerman et al, Baeten
et al, Celum et al, Dunne et al, Delany et al, Mbopi-Keou et
al, Augenbraun et al, LeGoff et al and Serwadda et al31 42e54
and Quinn et al55 to convert from differences in HIV viral
load
Asymptomatic/latent phase 1e4.75
Primary phase and symptomatic recurrence phase 1.5e4.0 times asymptomatic
cofactor
Cofactors for HSV-2 HIV cofactor per partnership for increasing HSV-2 infectivity: Using Celum et al, Corey et al, Freeman et al and Watson-
Jones et al45 56e58 and converting to probability using
Quinn et al55
Primary phase 1e2.5
Asymptomatic/latent phase 2e4
Symptomatic recurrence phase Same as primary
Condom efficacies Condom efficacy per sex act for HIV 80% to 95% Pinkerton et al59 60
Condom efficacy per sex act for HSV-2 and syphilis 40% to 70% Based on Wald et al, Oberle et al, Dobbins et al, Obasi et al
and Huerta et al37 61e65
Condom efficacy per sex act for Ng/Ct 60% to 90% Based on Holmes et al, Hooper et al, Austin et al, Barlow,
Joesof et al, Sanchez et al, Gaydos et al, Niccolai et al and
Zenilman et al 66e74
Ct, Chlamydia trachomatis; HSV, herpes simplex virus; Neisseria gonorrhoeae; STI, sexually transmitted infection.
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Table 3 Prior behavioural model input parameters sampled at the fitting stage to obtain the posterior parameter sets for Mysore and Belgaum for the
Avahan impact model
Types of model input Definition of model input Mysore Belgaum
Demography
Population size and demographic inputs Initial size of sexually active population 278000 (M) 268000 (M)
268000 (F) 257000(F)
Fraction of female general population
sexually active
75% to 95% 77% to 95%
Fraction of male general population
sexually active
Determined by available partnerships Determined by available partnerships
Average time spent sexually active 41.3 years (M) 41.5 years (M)
42.4 years (F) 42.2 years (F)
Entry rate into sexually active population
per year
12000 (M) 12000 (M)
11000 (F) 11000 (F)
Migration of female sex workers (FSWs) Proportion of FSWs migrating 0.3e0.44 0.05e0.20
Multiplicative cofactor increasing
prevalence of HIV among clients in sites to
which FSWs migrate
1e2 1e2
Sexual behaviour
Long-term partnerships of FSWs and
clients
Percentage of clients currently married/cohabiting by duration:
0e1 years and 2e4 years 68% 43% to 59%
5e9 years and 10+ years 68% 83% to 93%
Percentage of FSWs currently married/cohabiting by duration:
0e1 years 38.2% to 57.2% 9.8% to 40.3%
2e4 years 39.9% to 54.9% 11.6% to 39.9%
5e9 years 28.6% to 50.4% 21.5% to 48.6%
10+ years 23.1% to 46/7% 5.3% to 20.7%
Percentage of FSWs currently married/cohabiting by typology:
Home based 25.9% to 54.1% 11.4% to 29.7%
Brothel based 8.8% to 66.9% 13.1% to 28.9%
Street based 39.3% to 49.3% 9.0% to 43.9%
Average frequency of sex acts with
married/cohabiting partner for FSWs/
clients (per month)
5.9e8.2 (clients) 9.5e11.7 (clients)
5.9e8.2 (FSWs) 5.6e9.5 (FSWs)
Duration of long-term partnerships
(cohabiting/married) if FSW, years
8.6e13.0 16.6e21.7
Duration of long-term partnerships
between clients and low-risk females,
years
20e30 20e30
FSW sexual behaviour Average weekly frequency of clients for:
Home-based FSWs duration 0e1 years 2.5e5.1 5.5e26.1
Home-based FSWs duration 2e4 years 3.8e7.9 1.8e10.3
Home-based FSWs duration 5e9 years 2.8e8.2 5.7e10.0
Home-based FSWs duration 10+ years 4.6e14.6 7.0e11.0
Brothel-based FSWs duration 0e1 years 15e25 6.3e34.2
Brothel-based FSWs duration 2e4 years 12e45 13.5e26.2
Brothel-based FSWs duration 5e9 years 4e15 13.1e25.3
Brothel-based FSWs duration 10+ years 5.2e16.6 8.9e17.9
Street-based FSWs duration 0e1 years 6.5e9.2 4.8e13.6
Street-based FSWs duration 2e4 years 7.5e9.4 1.1e13.0
Street-based FSWs duration 5e9 years 7.2e9.8 2.4e10.2
Street-based FSWs duration 10+ years 6.5e9.1 3.8e10.2
Number of sex acts with each client 1e3 1e3
Average duration of sex work in months for:
Home-based FSWs 35e69 160e224
Brothel-based FSWs 49e189 94e127
Street-based FSWs 53e66 138e251
Client sexual behaviour Number of FSWs visited/month if:
Below median activity level 0.8e1.2 0.8e1.2
Above median activity level 2.9e3.8 2.32e2.78
Average duration of being client in months
if below/above median activity level
84e240/84e240 83e119/90e143
Continued
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that this decline began before Avahan started, around the year
2000, while in Mysore the decline probably started shortly after
Avahan, in 2004e2005. Modelled incidence and the prevalence
for hypothesis H1 for Mysore show similar trends (see supple-
mentary material). More details of the general characteristics of
the model runs and ﬁts are included in the supplementary
material.
In Mysore, the median relative decline in HIV prevalence in
2009 compared to 2004 (‘time decline’) under H2 was 36.2%
(95% CI 21% to 51%) in FSWs (median 25.6%, 95% CI 7% to
42% in clients), whereas the median relative decline in 2009
prevalence compared to a simulated scenario without any
increase in condom use since 2004 (‘intervention decline’) was
44.7% (95%CI 35% to 52%) in FSWs (37.9%, 95% CI 30% to 45%
in clients). In Belgaum, under H1, the median time decline was
47.6% (95% CI 39% to 58%) in FSWs (median 55.7%, 95% CI
48% to 66% in clients) while the median intervention decline
was actually lower at 23.1% (95% CI 17% to 30%) in FSWs
(28.4%, 95% CI 22% to 36% in clients). Thus, the time decline in
HIV prevalence slightly underestimates the intervention decline
in Mysore for hypothesis H2 and overestimates it in Belgaum for
hypothesis H1.
Intervention impact among high-risk groups
We estimated the impact of the increase in condom use
following the start of Avahan using the most likely hypothesis
as the simulated intervention group/population, and using the
null hypothesis H0 as the simulated matched control group/
population. In Mysore, the increase in condom use between 2004
and 2009 may have prevented 31.3% to 47.4% of new HIV
infections in FSWs and 32.7% to 47.2% in clients under
hypothesis H2 (ﬁgure 4 shows this in comparison to the impact
projections for hypothesis H1). Impact increases over time, with
58.7% to 82.2% of new HIV infections prevented among FSWs in
2008 and 64.1% to 85.1% among clients under hypothesis H2
(41.2% to 72.2% and 47.1% to 77.6% under H1).
In Belgaum, hypothesis H0, where condom use remains
constant from 2004 onwards, suggests no impact. In
Table 3 Continued
Types of model input Definition of model input Mysore Belgaum
Proportions of FSWs/clients by each
stratification
Percentage of female population who are
FSWs
0.3% to 1.4% 0.2% to 1.1%
Percentage of male population who are
clients
Determined by number of FSW
partnerships
Determined by number of FSW
partnerships
Proportion of FSWs that are:
Home based 0.08e0.15 0.23e0.50
Brothel based 0.00e0.01 0.31e0.61
Street based 0.85e0.91 0.11e0.24
Proportion of male clients who visit FSWs:
Below median level (ie, low activity
clients)
0.5 0.58e0.69
Above median level (ie, high activity
clients)
0.5 0.31e0.42
Condom use
Condom use in main partnerships Average consistency of condom use
between married/cohabiting partners per
sex act.
4.3% to 10.3% 5.2% to 12.7%
Condom use between FSWs and clients Fraction of sex acts with occasional clients for which a condom is used, by FSWs who:
Report ‘always’ using 0.81e0.93 0.81e0.93
Report often/sometimes using
Report ’never’ using
0.54e0.67 0.54e0.67
0.07e0.38 0.07e0.38
Fraction of FSWs who are consistent condom users:
At the start of the HIV epidemic in India 0e0.1 0e0.1
Under H0 and H1:
At first time point 0.111e0.228 0.286e0.422
At second time point 0.233e0.395 0.759e0.855
Under H1, at time of IBBA R2 0.615e0.729 0.855e0.926
Under H2:
At first time point 0.1e0.220 0.1e0.220
At second time point 0.321e0.416 0.321e0.416
At time of IBBA R2 0.777e0.847 0.777e0.847
Fraction of FSWs who report ‘sometimes/
often’ using condoms with occasional
clients at IBBA R2
0.245e0.367 0.074e0.145
Dates Start of HIV epidemic in India 1976e1985 1976e1985
Under H0 and H1:
At first time point 2002 2002
At second time point 2004 2005
At time of IBBA R2 2007 2008
Under H2:
At first time point 2004 2004
At second time point 2006 2006
At time of IBBA R2 2008 2008
FSW, female sex worker; H, hypothesis; IBBA, integrated behavioural and biological assessments; R, round.
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comparison, the H1 scenario projects that 24.8% to 43.2% of
new FSW HIV infections and 30.9% to 53.1% of new client
infections were prevented in Belgaum by the increase in condom
use between 2004 and 2009 (ﬁgure 4). As for Mysore, impact
increases over time in the H1 scenario, with 32.7% to 59.7% of
new infections in FSWs and 42.0% to 72.6% in clients prevented
in 2008.
DISCUSSION
With sufﬁcient data to inform model parameters and validate
model predictions, the use of mathematical models within
a Bayesian framework enables the testing of hypotheses about
the value or range of more uncertain parameters,77 78 such as the
evolution of condom use over time. In this analysis we have
tested whether condom use is likely to have increased following
the implementation of the Avahan intervention. In theory this
could have been done more directly if unbiased baseline data on
condom use had been collected; however, in practice it was not
possible because such data could only be collected once the
intervention was sufﬁciently well established to map and sample
FSWs.
The success rates obtained in the hypothesis-testing analysis
support the conclusion that in Mysore condom use during
commercial sex increased substantially after the beginning of the
intervention. This increase most likely occurred shortly after the
beginning of the intervention, as suggested by data on avail-
ability of condoms. Although there was no signiﬁcant decrease
in the FSW IBBA prevalence data between rounds 1 and 2, the
model suggests that, in the absence of an increase in condom use
after 2004, prevalence would have increased, and so to obtain the
required trend a signiﬁcant increase in condom use was required.
In Belgaum, the model results show that decreases in prevalence
alone from the IBBA surveys are insufﬁcient to distinguish
between the hypotheses of increased condom use as reported by
FSWs and constant condom use following the beginning of the
intervention. Without information from other sources, it is not
possible to deﬁnitely conclude that there has been an increase in
condom use in commercial sex in Belgaum. The results also
suggest that the level of condom use was higher in Belgaum
than in Mysore prior to 2004. In Belgaum, a smaller-scale
intervention was present for some years prior to 2004,79 before it
was scaled up by Avahan. Condom use by FSWswith clients may
therefore have been higher at the start of the intervention than in
Mysore, where there was no prior intervention.
The model results indicate that HIV incidence and prevalence
have declined over time. The decline occurred earlier in Belgaum
than in Mysore because condom use became widespread earlier,
but perhaps also because the epidemic matured earlier. In
Mysore, the decline roughly coincides with the beginning of the
intervention. This pattern of decrease in prevalence agrees with
that seen by Vickerman et al,4 and by Boily et al80 examining
ANC data. While this study only considers high-risk individuals,
the decline observed among FSWs and clients should translate to
a slower decline in the general population in both districts, as
shown in the analysis by Vickerman et al.4
The relative decline in HIV prevalence in Mysore in 2009
compared to the simulated control group (‘intervention decline’)
is higher than the decline over time since 2004 (‘time decline’).
This is because the epidemic was still growing in 2004. In
Belgaum, under the hypothesis of increasing condom use after
Table 4 Number of fits per million runs for each hypothesis (H) (fits to round (R)1 data only are shown for comparison to validate time trends of the
model in HIV prevalence)
Mysore Belgaum
H0: condom use
fixed since 2004
H1: condom use as
reconstructed from
IBBA round 2 data
H2: condom use follows
condom availability trends9
H0: condom use
fixed since 2004
H1: condom use as
reconstructed from
IBBA round 2 data
H2: condom use follows
condom availability
trends9
Fits to R1 FSW and
client IBBAs
0 48.3 86 11.3 9.7 0
Fits to R1+R2 FSW
and client IBBAs
0 36 (S) 82.7 (S) 9.7 8.3 (NS) 0 (S)
FSW, female sex worker; IBBA, integrated behavioural and biological assessments; NS, not statistically different to H0 at the 5% level using c
2 test; S, statistically significantly different to H0.
Figure 2 Prior parameter ranges for hypotheses H0eH2 reflecting the
proportion of female sex workers (FSWs) who are consistently using
condoms for (a) Mysore and (b) Belgaum. The upper and lower lines
show the range of the prior. Also shown is the data from the historic
condom reconstruction, and mean and 95% CIs for the FSW integrated
behavioural and biological assessment (IBBA) values.
Sex Transm Infect 2010;86(Suppl 1):i33ei43. doi:10.1136/sti.2009.038950 i39
Supplement
Avahan, the intervention decline is smaller than the time
decline, as the epidemic there was already declining prior to
Avahan. This highlights that time trends alone should not be
used to evaluate an intervention, and that modelling results are
important to complement prevalence data in carrying out an
evaluation.6 8 80
Strengths and limitations
The model described in this paper was speciﬁcally tailored to
reﬂect the behavioural and biological heterogeneities present in
these settings, with dynamical modelling of HSV-2 and syphilis
in addition to HIV in each site. It was parameterised using data
from multiple surveys among FSWs, clients and general
Figure 3 HIV prevalence over time for most likely hypothesis for (a) female sex workers (FSWs) and (b) clients in Mysore (H2); (c) FSWs and
(d) clients in Belgaum (H0); and (e) FSWs and (f) clients in Belgaum (H1). Shown on the graphs are median, 25th and 75th percentiles, and the 95%
credibility interval (lighter shaded area). For H1 Belgaum and H2 Mysore the prevalence of the simulated control groups is also shown (median, 25th and
75th percentiles, and 95% credibility interval). Also shown is the integrated behavioural and biological assessment (IBBA) prevalence data.
i40 Sex Transm Infect 2010;86(Suppl 1):i33ei43. doi:10.1136/sti.2009.038950
Supplement
population, and captured key epidemiological trends in HIV,
HSV-2 and syphilis by risk groups. This model also compared
well to an independent model by Vickerman et al,4 and it was
also validated with respect to time trends in HIV and FSW HIV
prevalences by typology.
The framework described in Boily et al8 was used to produce
point estimates and credibility intervals of intervention impact
by the creation of control groups that assumed no increase in
condom use. This control group gives the impact due to the
increase in condom use since the beginning of the intervention,
and, in situations where condom use would have increased
naturally even without an intervention to drive it, will over-
estimate intervention impact. Conversely, in the absence of
a likely increase in condom use following Avahan, as may have
been the case in Belgaum, this choice of control group results in
the model projecting no HIV infections averted, while it is
possible that there would still have been a decline in condom use
in this situation without an intervention to sustain it. Indeed,
analysis of a slow, modest decrease in consistent condom use of
10% over 5 years suggests that even such a small decline in
condom use leads to a large impact (17.3% to 29.7% additional
new FSWHIV infections between 2004e2009 due to the decrease
in condom use), and thus the contribution of the intervention in
sustaining condom use is important, although it is difﬁcult to
attribute directly.
The precision of the estimates was limited by data availability.
In both districts, the ﬁtting success rate was modest because
conservative (wide) prior ranges were used for most parameters
to capture their uncertainty, and because the model had to ﬁt
seven separate prevalence outcomes. If more data were available,
then it would be possible to use this additional information to
reduce the width of these priors and so possibly identify a higher
proportion of model ﬁts. This would allow a stronger compar-
ison between the condom use scenarios, and would better reﬂect
uncertainty in the impact projections. HIV prevalence data for
earlier in the epidemic would also enable us to better constrain
the trajectory of the early epidemic and so rule out unlikely
epidemics with high early prevalence. However, using
a constraint such as FSW prevalence being <10% in 1985 did not
change the impact estimates signiﬁcantly (data not shown).
The picture is further complicated in Belgaum because the
ﬁrst IBBA survey was carried out 16 months after the start of
the Avahan initiative, and so behavioural and epidemiological
data reﬂected a situation in which Avahan was already present
and where consistent condom use rates reported by FSW in the
2005 IBBA were already very high, at 91%. In contrast, the
survey in Mysore is likely to be more comparable to the pre-
Avahan baseline as it took place 8 months after the start of
Avahan. It is difﬁcult to quantify the impact of a change in
behaviour in situations where there was a pre-existing inter-
vention and a long delay between the start of the intervention
and the ﬁrst IBBA survey, such as in Belgaum. Impact estimation
is more uncertain in such settings because it is hard to deﬁne and
simulate a control group reﬂecting how condom use would have
decreased without the intervention, for which no data are
available. An additional round of behavioural and HIV preva-
lence data for FSWs in Belgaum could help to further inform
impact estimates by giving extra information about how the
epidemic there is changing.
In Belgaum, the low number of ﬁts from the model to the
prevalence data may be largely explained by the difﬁculty of
ﬁtting the relatively high HIV prevalence in clients. This anal-
ysis modelled the transmission of HIV/STIs among urban
clients, since the IBBA was carried out in urban areas where the
intervention started. However the size of the FSW population is
higher in rural areas, and as city clients may also go to smaller
towns and villages to visit FSWs, the urban client HIV preva-
lence may be inﬂuenced by the large rural FSW population.
Future data collection strategies for programme evaluation
should be adapted to reﬂect the reality of how the epidemic is
driven and the nature of the intervention.
Conclusions
Dynamical modelling, used within a Bayesian framework, is
useful for testing hypotheses and providing informative and less
subjective impact estimates on which to base decisions. This
method of comparing proportions of ﬁts of different scenarios is
relatively straightforward to implement, as shown here and in
another recent analysis,77 and helps to further augment survey
ﬁndings of behaviours that are prone to reporting biases, such as
condom use.
This analysis suggests that the HIVepidemics in Belgaum and
Mysore are declining. In Belgaum, it is probable that the decline
in HIV prevalence started before the beginning of the Avahan
intervention, since condom use by FSWs with their clients was
already high in this district due to pre-existing interventions.
The model, using current prevalence data alone, is unable to
distinguish between scenarios where condom use in commercial
sex was sustained at existing levels and where it increased after
Avahan. If there was a rise in condom use, as suggested by other
data9 and equally likely compared to the null hypothesis from
this method, this increase would have averted 24.8% to 43.2% of
HIV infections in FSWs and 30.9% to 53.1% of infections in
clients between 2004 and 2009. If, however, Avahan only
sustained the existing level of condom use attained by FSWs prior
to Avahan, this is still important for controlling the epidemic, as
even a small, gradual decline in condom use can greatly increase
the number of new infections. This conclusion on impact, of
including both scenarios, is conservative (which is deemed pref-
erable), since the difference in proportion of ﬁts between the
hypotheses where condom use does or does not increase after
2004 is small. However, combined with the additional data
Figure 4 Fraction of new HIV infections averted over a 5-year period
from 2004 in female sex workers (FSWs) and clients as a result of
increases in condom use for (A) Mysore under hypotheses H1 and H2 and
(B) Belgaum under hypotheses H1. Shown on the graph are the median
(middle line in the box), 25th and 75th percentiles (box) and the 95%
credibility interval (whiskers). Belgaum hypothesis H0 corresponds to no
impact, and is not shown.
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presented in Bradley et al9 regarding the availability of condoms
in Belgaum, it can be argued that it is likely that there has been an
increase in condom use since the start of Avahan.
In Mysore, the ﬁndings strongly suggest that condom use
during commercial sex has increased since the introduction of
the Avahan programme, and that this increase in condom use
has averted 31.3% to 47.4% of HIV infections in FSWs and
32.7% to 47.2% in clients in Mysore over the ﬁrst 5 years.
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